REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 1.30
High: 1.30
Low: 1.30
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confirmation of Twitter account

16 Apr 2020 07:00

RNS Number : 8079J
Physiomics PLC
16 April 2020
 

16 April 2020

 

Physiomics plc

("Physiomics") or (the "Company")

 

Confirmation of Twitter account

 

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, would like to note that its only official twitter account is @Physiomics.

 

It has come to the Company's attention that a twitter account with a similar name, @Physiomics1, which was set up in February this year, has been tweeting and retweeting content relating to the Company. This account is not endorsed by and does not come from the Company and we have requested that it be closed.

 

The Company will continue to keep shareholders update on any material developments in the ordinary course, in accordance with its regulatory obligations.

 

Enquiries:

 

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

Strand Hanson Ltd (NOMAD)

Richard Tulloch & James Dance

+44 (0)20 7409 3494

 

Hybridan LLP (Broker)

Claire Louise Noyce

+44 (0)20 3764 2341

 

Notes to Editor

 

About Physiomics

 

Physiomics® is an oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions. The predictive capability of Virtual Tumour has been confirmed by 55 projects, involving over 25 targets and 60 drugs, and has worked with clients such as Merck KGaA, Merck & Co, Bayer and Lilly.

 

Based in Oxford UK, the Company works with clients worldwide to support their pre-clinical and clinical oncology development programs. Its team of scientists and computer modelling experts provide bespoke solutions encompassing data, analytics and insight.

 

Physiomics senior management has academic and commercial expertise, including over 90 years collectively of working in oncology and/or computational biology and over 100 publications in peer reviewed journals.

 

For more information please visit:

www.physiomics-plc.com

www.twitter.com/Physiomics

www.linkedin.com/company/physiomics-plc/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFELLFBZLBBBB
Date   Source Headline
1st Jul 20137:00 amRNSAdditional SEDA Drawdown
24th Jun 20137:00 amRNSWins Poster Award
20th Jun 20134:28 pmRNSAward of Grant
11th Jun 20137:00 amRNSPopulation Approach Group Europe
6th Jun 20137:00 amRNSVirtual Tumour Clinical Contract
8th Apr 20138:03 amRNSPhysiomics to present new developments
25th Mar 20137:00 amRNSPhysiomics to provide cardiac toxicity modelling
18th Mar 20137:00 amRNSNew clinical PK/PD modelling service
13th Feb 201311:10 amRNSIssue of Options
11th Feb 20133:23 pmRNSDirector Declaration
8th Feb 20137:00 amRNSHalf Yearly Report
22nd Jan 20137:00 amRNSSEDA Arrangement
7th Jan 20137:00 amRNSRecruitment of Senior Scientist with Clinical PK/P
18th Dec 20129:46 amRNSFrench R&D Tax Credit Accreditation
17th Dec 201212:29 pmRNSResult of AGM
14th Nov 20127:00 amRNSFinal Results for the year ended 30 June 2012
8th Oct 20128:38 amRNSNew US Business Development Consultant
10th Aug 20127:53 amRNSNew Agreement to optimise oncology combination
7th Aug 20123:57 pmRNSStmnt re Share Price Movement
4th Jul 20123:25 pmRNSTrading Update
7th Jun 201211:42 amRNSPresentation at the 2012 PAGE 21st Annual Meeting
29th May 201212:37 pmRNSShare Price Movement
21st May 201212:03 pmRNSDirector/PDMR Shareholding
30th Apr 20127:00 amRNSTotal Voting Rights
26th Apr 20128:49 amRNSIssue of Equity
29th Mar 20127:00 amRNSParticipation in AACR Annual Meeting 2012
16th Mar 20127:00 amRNSPhysiomics to present at the Bio-Europe Conference
7th Mar 20127:00 amRNSHalf Yearly Report
1st Mar 20127:20 amRNSNew Agreement with Global Pharma Company
31st Jan 201211:57 amRNSPhysiomics to enter new therapeutic area
20th Dec 201112:05 pmRNSIssue of Options
18th Nov 201110:07 amRNSResult of AGM
9th Nov 20115:01 pmRNSIssue of Options
2nd Nov 20117:00 amRNSExecution of New Agreement
19th Oct 20117:00 amRNSScientific Board Update
11th Oct 20118:39 amRNSFinal Results
29th Sep 201110:17 amRNSJoint servs alliance executed with Jubilant Biosys
27th May 201110:33 amRNSIssue of Equity
13th May 20114:34 pmRNSIssue of Equity
4th May 20117:00 amRNSNew collaboration with Pharmacometrics Limited
28th Apr 20119:46 amRNSTotal Voting Rights
6th Apr 20117:00 amRNSIssue of Equity
5th Apr 20117:00 amRNSUpcoming Presentation
1st Apr 201110:32 amRNSResults Update
29th Mar 20111:10 pmRNSIssue of Equity
9th Mar 20117:00 amRNSHalf Yearly Report
8th Mar 20117:00 amRNSUpdate: Joint services alliance w. Jubilant Biosys
15th Feb 20114:56 pmRNSStmnt re Share Price Movement
9th Feb 20119:25 amRNSStmnt re Share Price Movement
8th Feb 201111:47 amRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.